Online citations, reference lists, and bibliographies.
← Back to Search

Glycans In Nanomedicine, Impact And Perspectives.

Susanna Sampaolesi, F. Nicotra, L. Russo
Published 2019 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Glycans have been selected by nature for both structural and 'recognition' purposes. Taking inspiration from nature, nanomedicine exploits glycans not only as structural constituents of nanoparticles and nanostructured biomaterials but also as selective interactors of such glyco-nanotools. Surface glycosylation of nanoparticles finds application in targeting specific cells, whereas recent findings give evidence that the glycan content of cell microenvironment is able to induce the cell fate. This review will highlight the role of glycans in nanomedicine, schematizing the different uses and roles in drug-delivery systems and in biomaterials for regenerative medicine.
This paper references
10.1002/JBM.A.31407
Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
Z. Liu (2007)
10.1016/J.JCONREL.2007.05.015
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
T. Ishida (2007)
10.1016/J.CARBPOL.2011.07.058
Biocompatible alginate/nano bioactive glass ceramic composite scaffolds for periodontal tissue regeneration
S. Srinivasan (2012)
10.1039/c2cs35420a
Glyconanoparticles as multifunctional and multimodal carbohydrate systems.
M. Marradi (2013)
10.1016/j.ijpharm.2009.04.009
Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
F. Oyarzun-Ampuero (2009)
10.3109/1061186X.2011.654121
Chitosan nanoparticles: a survey of preparation methods
A. Grenha (2012)
10.1016/J.CARBPOL.2009.02.019
Evaluation of Alginate/Chitosan nanoparticles as antisense delivery vector: Formulation, optimization and in vitro characterization
Tarane Gazori (2009)
10.1002/mabi.201000456
Antitumor efficacy of doxorubicin released from crosslinked nanoparticulate chondroitin sulfate/chitosan polyelectrolyte complexes.
Hun-Yu Tsai (2011)
10.1016/S1359-0294(03)00099-2
Interaction in polysaccharide solutions and gels
K. Nishinari (2003)
10.1021/jacs.5b00592
Probing cell-surface carbohydrate binding proteins with dual-modal glycan-conjugated nanoparticles.
Sungjin Park (2015)
10.1172/JCI116469
Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-alpha-dependent mechanism in murine macrophages.
P. Noble (1993)
10.1073/PNAS.85.18.6949
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.
A. Gabizon (1988)
10.1016/j.nantod.2015.01.005
Core-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical Translation.
M. Talelli (2015)
10.1016/J.IJBIOMAC.2014.09.043
Betaine conjugated cationic pullulan as effective gene carrier.
Lizebona August Ambattu (2015)
10.1016/j.ijpharm.2008.03.039
Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Aihua Lin (2008)
10.1016/0014-5793(73)80394-1
Drug entrapment in liposomes
G. Gregoriadis (1973)
10.1021/nl500388h
Imaging early endothelial inflammation following stroke by core shell silica superparamagnetic glyconanoparticles that target selectin.
T. Farr (2014)
10.1016/J.AJPS.2015.07.003
Development of pectin nanoparticles through mechanical homogenization for dissolution enhancement of itraconazole
K. Burapapadh (2016)
10.1039/c6bm00088f
Sugared biomaterial binding lectins: achievements and perspectives.
P. Bojarová (2016)
10.1093/GLYCOB/9.8.823
Glycosylation of a CNS-specific extracellular matrix glycoprotein, tenascin-R, is dominated by O-linked sialylated glycans and "brain-type" neutral N-glycans.
S. Zamze (1999)
10.1016/j.fob.2014.10.004
N-Glycosylation of extracellular matrix protein 1 (ECM1) regulates its secretion, which is unrelated to lipoid proteinosis
S. Uematsu (2014)
10.1002/PAT.3266
Polysaccharide biomaterials for drug delivery and regenerative engineering
N. Shelke (2014)
10.1016/j.biomaterials.2009.02.036
Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Y. Lin (2009)
10.1002/APP.39934
In situ gelling polysaccharide‐based hydrogel for cell and drug delivery in tissue engineering
Y. Cheng (2014)
10.1097/01.TA.0000199392.91772.44
The Chitosan-Based Hemostatic Dressing: Experience in Current Combat Operations.
J. McManus (2006)
10.1021/mp200278s
Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
S. H. Yuk (2012)
10.1210/en.2009-1082
Nanoparticles and the immune system.
Banu S. Zolnik (2010)
10.1038/nrn2285
Polysialic acid in the plasticity of the developing and adult vertebrate nervous system
U. Rutishauser (2008)
10.1021/ja100455c
Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging.
Kheireddine El-Boubbou (2010)
10.1016/j.biomaterials.2013.09.094
Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
Xinyi Jiang (2014)
10.1021/bm501532e
Advanced nanocarriers based on heparin and its derivatives for cancer management.
Xiaoye Yang (2015)
10.1016/j.carbpol.2016.05.049
A review of chitosan and its derivatives in bone tissue engineering.
R. LogithKumar (2016)
10.1016/S0142-9612(01)00332-5
Usefulness as guided bone regeneration membrane of the alginate membrane.
Y. Ueyama (2002)
10.1177/00220345010800111501
Cell-interactive Alginate Hydrogels for Bone Tissue Engineering
E. Alsberg (2001)
10.1016/S0142-9612(00)00052-1
Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats.
J. S. Pieper (2000)
10.1021/bc500467u
Effective targeting of DC-SIGN by α-fucosylamide functionalized gold nanoparticles.
D. Arosio (2014)
10.1002/app.46154
Advanced architectures in the design of responsive polymers for cancer nanomedicine.
Angela M. Wagner (2018)
10.1016/S0952-7915(98)80031-9
The mannose receptor is a pattern recognition receptor involved in host defense.
P. Stahl (1998)
10.1021/la404310p
Thiol-ene mediated neoglycosylation of collagen patches: a preliminary study.
L. Russo (2014)
10.1016/S0378-5173(01)00915-2
Alginate/chitosan particulate systems for sodium diclofenac release.
M. González-Rodríguez (2002)
10.1002/POLA.26255
Polyelectrolyte complex nanoparticles from chitosan and poly(acrylic acid) and Polystyrene‐block‐poly(acrylic acid)
Julien Rolland (2012)
10.2147/IJN.S17296
Recent advances of chitosan nanoparticles as drug carriers
J. Wang (2011)
10.1039/C3TB20138D
(Oligo)mannose functionalized hydroxyethyl starch nanocapsules: en route to drug delivery systems with targeting properties.
Hélène Freichels (2013)
10.1167/iovs.07-1077
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
10.1016/S0142-9612(00)00126-5
Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review.
Jung Kee Suh (2000)
10.1016/j.ijpharm.2011.08.046
Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Hua-ding Lu (2011)
10.1039/b902134e
Dextran Coated Gadolinium Phosphate Nanoparticles for Magnetic Resonance Tumor Imaging
Hiroki Hifumi (2009)
10.1016/S0142-9612(99)00011-3
Porous chitosan scaffolds for tissue engineering.
S. Madihally (1999)
10.1007/s10989-004-2433-4
Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Y. Chen (2004)
10.1016/j.jconrel.2011.04.007
Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine.
G. Prestwich (2011)
10.1074/jbc.M804526200
N-Glycosylation of Laminin-332 Regulates Its Biological Functions
Y. Kariya (2008)
10.1016/J.PROGPOLYMSCI.2011.06.003
Alginate: properties and biomedical applications.
K. Lee (2012)
10.1080/07328303.2018.1462372
Immobilization of glycans on solid surfaces for application in glycomics
Crystal O’Neil (2018)
10.1126/sciadv.aaq0597
Implantation of hyaluronic acid hydrogel prevents the pain phenotype in a rat model of intervertebral disc injury
Isma Liza Mohd Isa (2018)
10.1021/ac701969u
Dextran-coated gold nanoparticles for the assessment of antimicrobial susceptibility.
S. Nath (2008)
10.1016/S0928-0987(03)00102-7
Formulation and characterization of DNA-polyethylenimine-dextran sulfate nanoparticles.
W. Tiyaboonchai (2003)
10.1016/J.JCONREL.2004.08.010
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
S. Agnihotri (2004)
10.1016/S0304-3940(98)00924-0
Cat peripheral nerve regeneration across 50 mm gap repaired with a novel nerve guide composed of freeze-dried alginate gel
Y. Suzuki (1999)
10.1166/JBN.2014.1753
Collagen functionalized bioactive nanofiber matrices for osteogenic differentiation of mesenchymal stem cells: bone tissue engineering.
Y. Cheng (2014)
10.1016/j.ijpharm.2009.07.028
Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
N. Csaba (2009)
10.1016/J.JSS.2005.12.013
Therapeutic potential of chitosan and its derivatives in regenerative medicine.
Chunmeng Shi (2006)
10.1016/J.BBAGEN.2005.12.020
Galectin-3: an open-ended story.
J. Dumić (2006)
10.1016/J.JCONREL.2006.03.007
Composite membrane of bacterially-derived cellulose and molecularly imprinted polymer for use as a transdermal enantioselective controlled-release system of racemic propranolol.
Chatchada Bodhibukkana (2006)
10.1182/blood-2009-12-257386
In vivo targeting of B-cell lymphoma with glycan ligands of CD22.
Weihsu C Chen (2010)
10.1016/j.carbpol.2015.06.102
Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells.
Y. Zhang (2015)
10.1021/cn400222s
Neoglucosylated collagen matrices drive neuronal cells to differentiate.
L. Russo (2014)
10.1016/j.actbio.2013.02.016
Silk fibroin/chondroitin sulfate/hyaluronic acid ternary scaffolds for dermal tissue reconstruction.
Shuqin Yan (2013)
10.1016/J.BIOMATERIALS.2006.02.031
Cellulose-based scaffold materials for cartilage tissue engineering.
F. Müller (2006)
10.1021/bm300578p
Glycan-targeted virus-like nanoparticles for photodynamic therapy.
Jin-Kyu Rhee (2012)
10.1021/bc200606s
Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
Raymond P. Briñas (2012)
10.1038/srep21629
Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells
L. Venturelli (2016)
10.1021/la500491c
Characterization of self-assembled polyelectrolyte complex nanoparticles formed from chitosan and pectin.
N. P. Birch (2014)
10.1021/nn204543c
Monosaccharides versus PEG-functionalized NPs: influence in the cellular uptake.
María Moros (2012)
10.1016/j.trecan.2018.05.009
Glycosylation and Integrin Regulation in Cancer.
Grazia Marsico (2018)
10.1016/0014-4827(86)90602-6
Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages.
J. Schlepper-Schäfer (1986)
10.1016/j.ejps.2013.04.018
Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
M. Dionísio (2013)
10.1016/j.biomaterials.2009.01.020
Injectable chitosan-based hydrogels for cartilage tissue engineering.
R. Jin (2009)
10.1039/b806051g
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity.
Elodie Boisselier (2009)
10.1097/DAD.0b013e31816a8c5b
Effects of Extracellular Matrix Glycosylation on Proliferation and Apoptosis of Human Dermal Fibroblasts Via the Receptor for Advanced Glycosylated End Products
Y. Niu (2008)
10.1016/j.actbio.2013.09.005
Effect of addition of hyaluronic acids on the osteoconductivity and biodegradability of synthetic octacalcium phosphate.
K. Suzuki (2014)
10.1016/j.ijpharm.2016.02.012
Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
Shabnam Tarvirdipour (2016)
10.1021/ar200084x
Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
C. Tassa (2011)
10.1002/adma.201003963
Hyaluronic acid hydrogels for biomedical applications.
J. Burdick (2011)
10.1016/j.actbio.2018.06.038
Polycaprolactone/polysialic acid hybrid, multifunctional nanofiber scaffolds for treatment of spinal cord injury.
S. Zhang (2018)
10.1111/joim.12486
Vascular proteomics in metabolic and cardiovascular diseases
M. Lynch (2016)
10.1016/J.BIOMATERIALS.2005.03.016
Chitosan: a versatile biopolymer for orthopaedic tissue-engineering.
A. Di Martino (2005)
10.1016/j.carbpol.2017.04.089
Pullulan: A novel molecule for biomedical applications.
R. Singh (2017)
10.1039/C3RA40408K
Glucosamine grafting on poly(ε-caprolactone): a novel glycated polyester as a substrate for tissue engineering
L. Russo (2013)
10.3389/fonc.2014.00059
Sweet and Sour: The Impact of Differential Glycosylation in Cancer Cells Undergoing Epithelial–Mesenchymal Transition
L. Freire-de-Lima (2014)
10.1016/j.jconrel.2009.08.012
Nanoparticles made from novel starch derivatives for transdermal drug delivery.
M. J. Santander-Ortega (2010)
10.2174/156802608783790974
Biologically active chitosan systems for tissue engineering and regenerative medicine.
T. Jiang (2008)
10.1021/acsami.5b08270
Different Sialoside Epitopes on Collagen Film Surfaces Direct Mesenchymal Stem Cell Fate.
A. Sgambato (2016)
10.1016/j.biomaterials.2009.09.063
The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering.
C. Murphy (2010)
10.1038/nrc1649
The sweet and sour of cancer: glycans as novel therapeutic targets
M. Fuster (2005)
10.1016/j.biomaterials.2013.02.028
Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
Y. Lin (2013)
10.1002/chem.201602156
Glycomics: New Challenges and Opportunities in Regenerative Medicine.
L. Russo (2016)
10.1016/j.biomaterials.2009.09.030
Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
K. Choi (2010)
10.1016/j.jbiosc.2008.09.020
Type II collagen-chondroitin sulfate-hyaluronan scaffold cross-linked by genipin for cartilage tissue engineering.
Chih-Sheng Ko (2009)
10.3390/ma8030832
Eudragit S100 Coated Citrus Pectin Nanoparticles for Colon Targeting of 5-Fluorouracil
M. Subudhi (2015)
10.1016/j.ejps.2010.04.004
Lactosaminated human albumin, a hepatotropic carrier of drugs.
L. Fiume (2010)
10.1038/nmat3776
Stimuli-responsive nanocarriers for drug delivery.
S. Mura (2013)
10.1038/sj.gt.3301140
Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system
M. Nishikawa (2000)
10.1016/j.carbpol.2015.11.006
Preparation of starch nanoparticles in water in oil microemulsion system and their drug delivery properties.
X. Wang (2016)
10.1016/J.BIOMATERIALS.2005.10.031
A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications.
T. C. Flanagan (2006)
10.1007/s11095-007-9367-4
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
B. Sarmento (2007)
10.1002/sctm.16-0116
Current and Future Perspectives on Alginate Encapsulated Pancreatic Islet
B. Strand (2017)
10.1021/pr400079d
Site-specific quantitative analysis of overglycosylation of collagen in osteogenesis imperfecta using hydrazide chemistry and SILAC.
Y. Taga (2013)
10.1016/j.cis.2014.03.009
Preparation methods of alginate nanoparticles.
J. P. Paques (2014)
10.1016/j.jmb.2011.03.042
Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.
M. Marradi (2011)
10.1039/c6bm00335d
Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.
O. Varghese (2016)
10.1007/s11468-011-9307-3
Binding of Escherichia coli to Functionalized Gold Nanoparticles
Pallavi Vedantam (2012)
10.1016/j.carbpol.2015.07.063
Chondroitin sulfate-based nanocarriers for drug/gene delivery.
Lili Zhao (2015)
10.1039/B402025A
Magnetic nanoparticle design for medical diagnosis and therapy
S. Mornet (2004)
10.1021/MA0209592
Cationic Polysaccharides for Gene Delivery
T. Azzam (2002)
10.1016/j.carbpol.2012.10.071
Present status and applications of bacterial cellulose-based materials for skin tissue repair.
Lina Fu (2013)
10.3390/gels2040028
Bioresponsive Hydrogels: Chemical Strategies and Perspectives in Tissue Engineering
Antonella Sgambato (2016)
10.1016/j.jconrel.2015.01.040
Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Cynthia M. Fehres (2015)
10.1002/term.2398
Medical application of glycosaminoglycans: a review
Alexander Köwitsch (2018)
10.1016/S0142-9612(03)00167-4
Evaluation of sodium alginate for bone marrow cell tissue engineering.
L. Wang (2003)
10.1002/BIT.10605
Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds.
Jennie Baier Leach (2003)
10.1016/j.biomaterials.2014.02.006
Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Xiongwei Deng (2014)
10.1016/J.BIOMATERIALS.2005.06.008
Galactose-carrying polymers as extracellular matrices for liver tissue engineering.
Chong-su Cho (2006)
10.1111/j.1365-2567.2006.02506.x
Mannan‐mediated gene delivery for cancer immunotherapy
C. Tang (2007)
10.1007/s11060-005-9059-z
The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma
A. Jordan (2005)
10.1039/C5TB00767D
Highly flexible silica/chitosan hybrid scaffolds with oriented pores for tissue regeneration.
D. Wang (2015)
10.1002/9780470513774.CH12
Hyaluronan and angiogenesis.
D. West (1989)
10.1021/LA053009T
Porous structures of polymer films prepared by spin coating with mixed solvents under humid condition.
M. Park (2006)
10.1016/j.jconrel.2015.06.033
MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses.
M. Boks (2015)
10.1016/J.JCONREL.2004.01.022
Hydrophobized dextran-spermine conjugate as potential vector for in vitro gene transfection.
T. Azzam (2004)
10.1002/term.1519
Chitosan–chondroitin sulphate nanoparticles for controlled delivery of platelet lysates in bone regenerative medicine
V. E. Santo (2012)
10.1042/BJ1240058P
Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases.
G. Gregoriadis (1971)
10.1016/j.carbpol.2012.04.057
Chitosan, hyaluronan and chondroitin sulfate in tissue engineering for cartilage regeneration: a review.
R. Muzzarelli (2012)
10.1016/j.biomaterials.2013.01.076
The effective nuclear delivery of doxorubicin from dextran-coated gold nanoparticles larger than nuclear pores.
H. Jang (2013)
10.1016/j.ejps.2016.01.004
Chitosan-pectin hybrid nanoparticles prepared by coating and blending techniques.
A. Rampino (2016)
10.1002/JBM.A.31406
A study on polysialic acid as a biomaterial for cell culture applications.
Y. Stark (2008)
10.1002/bip.21334
Polysaccharide‐modified synthetic polymeric biomaterials
Aaron D Baldwin (2010)
10.1016/J.BRAINRESREV.2007.05.014
Polysialic acid–neural cell adhesion molecule in brain plasticity: From synapses to integration of new neurons
E. Gascon (2007)
10.1089/jop.2012.0193
Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
Wanachat Chaiyasan (2013)
10.1016/J.POLYMER.2012.10.032
Microencapsulated chitosan–dextran sulfate nanoparticles for controled delivery of bioactive molecules and cells in bone regeneration
J. Valente (2013)
10.1021/mp200213r
Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells.
B. Carrillo-Conde (2011)
10.1056/NEJM197609302951406
The carrier potential of liposomes in biology and medicine (second of two parts).
G. Gregoriadis (1976)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar